Pages that link to "Q77068469"
Jump to navigation
Jump to search
The following pages link to Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features--problems involved in the architectural grading system (Q77068469):
Displaying 43 items.
- Expression of lysophosphatidic acid acyltransferase beta (LPAAT-beta) in ovarian carcinoma: correlation with tumour grading and prognosis (Q24650522) (← links)
- An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas (Q33960748) (← links)
- Analysis of FoxP3 T-regulatory cells and CD8 T-cells in ovarian carcinoma: location and tumor infiltration patterns are key prognostic markers (Q34445730) (← links)
- Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum (Q34729698) (← links)
- Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer (Q34756429) (← links)
- Metabolomic Characterization of Ovarian Epithelial Carcinomas by HRMAS-NMR Spectroscopy (Q34960082) (← links)
- The transcriptomic profile of ovarian cancer grading (Q35032309) (← links)
- Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer (Q35195618) (← links)
- Morphological effects of chemotherapy on ovarian carcinoma (Q35588636) (← links)
- Stromal Expression of Fibroblast Activation Protein Alpha (FAP) Predicts Platinum Resistance and Shorter Recurrence in patients with Epithelial Ovarian Cancer (Q35666119) (← links)
- Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma (Q35788745) (← links)
- A binary histologic grading system for ovarian serous carcinoma is an independent prognostic factor: a population-based study of 4317 women diagnosed in Denmark 1978-2006 (Q35980522) (← links)
- CA-125-indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery (Q36621252) (← links)
- Differential gene expression identifies subgroups of ovarian carcinoma (Q36673528) (← links)
- Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer (Q36694163) (← links)
- Papillary serous carcinoma in ovaries of normal size: a clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma (Q36769540) (← links)
- Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma (Q36979335) (← links)
- Mutational analysis of KRAS, BRAF, and TP53 genes of ovarian serous carcinomas in Korean women (Q37183300) (← links)
- Low-grade serous ovarian cancer: a unique disease (Q37301334) (← links)
- Secondary cytoreduction surgery improves prognosis in platinum-sensitive recurrent ovarian cancer (Q37356602) (← links)
- Pattern of triple negative epithelial ovarian cancer in indigenous African women (Q37384267) (← links)
- Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository (Q37725019) (← links)
- Fertility-sparing surgery in patients with clear-cell carcinoma of the ovary: Is it possible? (Q37948027) (← links)
- Low-grade and high-grade serous Mullerian carcinoma: review and analysis of publicly available gene expression profiles (Q38068618) (← links)
- Topoisomerase IIalpha mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis (Q38422475) (← links)
- Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer (Q40344519) (← links)
- Immunohistochemical markers of cell cycle control applied to ovarian and primary peritoneal surface epithelial neoplasms: p21(WAF1/CIP1) predicts survival and good response to platinin-based chemotherapy (Q41673578) (← links)
- Hormone-receptor expression status of epithelial ovarian cancer in Ibadan, South-western Nigeria (Q46747718) (← links)
- Correlation Between Immunohistochemical Biomarkers Expression and Prognosis of Ovarian Carcinomas in Tunisian Patients (Q47132946) (← links)
- Comparison of the usefulness between a new universal grading system for epithelial ovarian cancer and the FIGO grading system. (Q52952013) (← links)
- [Ovarian carcinoma. Do the subtypes reflect different diseases?]. (Q53042875) (← links)
- Is the two-tier ovarian serous carcinoma grading system potentially useful in stratifying uterine serous carcinoma? A large multi-institutional analysis. (Q53082153) (← links)
- High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinoma. (Q53396256) (← links)
- A Pathological Study Using 2014 WHO Criteria Reveals Poor Prognosis of Grade 3 Ovarian Endometrioid Carcinomas. (Q55465801) (← links)
- Pathology and classification of ovarian tumors (Q73357578) (← links)
- Prospects for improving staging of ovarian cancers (Q73523872) (← links)
- Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum (Q79862089) (← links)
- Sustained response to bevacizumab in refractory well-differentiated ovarian neoplasms (Q83334275) (← links)
- Low-grade serous primary peritoneal carcinoma (Q83597688) (← links)
- Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant (Q83636947) (← links)
- Low membranous expression of beta-catenin and high mitotic count predict poor prognosis in endometrioid carcinoma of the ovary (Q84700413) (← links)
- [Histological grading of epithelial ovarian cancer. Review and recommendation] (Q87457789) (← links)
- Identification and validation of core genes for serous ovarian adenocarcinoma via bioinformatics analysis (Q99551772) (← links)